Omega-3 Experts' Blog

Therapeutic potential of DHA in psychiatric disorders

The relationship between the omega-3 polyunsaturated fatty acid DHA and maturation of the cortical circuit suggests it may be possible to act on the risk factor posed by DHA deficiency in various psychiatric disorders. Both...

Read more

EPA/DHA supplementation could permit a reduction to the methylphenidate dose

Attention deficit hyperactivity disorder (ADHD) is normally treated with stimulants, such as methylphenidate, due to their clinical efficacy. However interest in non-pharmacological treatments has increased due to the secondary...

Read more

Consumption of fatty acid-rich fish improves paroxetine response

Up to 50% of patients with major depressive disorder (MDD) do not respond to treatment with selective serotonin re-uptake inhibitors (SSRIs). A study presented at the 27th European College of Neuropsychopharmacology Congress (...

Read more

EPA in the treatment of hypertriglyceridaemia in diabetes type 2

Cardiovascular disease (CVD) is the main cause of death in patients with diabetes type 2 (with a rate two to four times higher than among the non-diabetic population). For this reason, the guidelines of the American Diabetes...

Read more